Voglibose
Composition
The formulation contains Voglibose as the active ingredient.
Indications
Type 2 diabetes mellitus
Side effects
Hypoglycemia, flatulence
Precautions
Monitor blood glucose levels regularly
Contraindications
Inflammatory bowel disease, intestinal obstruction, hypersensitivity
Dosage and administration
As directed by healthcare provider
Countries
Japan, India
Available Forms
Tablets
Manufacturing Services
Third Party Manufacturing Company WHO, GMP, EUGMP, USFDA, In India | Contract Manufacturing Organization (CMO) WHO, GMP, EUGMP, USFDA Services in India, Mumbai, Navi Mumbai| Contract Development and Manufacturing Organization (CDMO) WHO, GMP, EUGMP, USFDA - Services in India | Pharmaceutical Contract Manufacturing Company WHO, GMP, EUGMP, USFDA in Navi Mumbai, India | Top Pharmaceutical Product Exporters, Suppliers, Distributer WHO, GMP, EUGMP, USFDA in Mumbai